FULC logo

Fulcrum Therapeutics (FULC) Shareholders Equity

Annual Shareholders Equity

$243.03 M
+$7.84 M+3.33%

December 1, 2024


Summary


Performance

FULC Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFULCbalance sheetmetrics:

Quarterly Shareholders Equity

$243.03 M
-$14.26 M-5.54%

December 31, 2024


Summary


Performance

FULC Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFULCbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

FULC Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3.3%+3.3%
3 y3 years+14.9%+3.3%
5 y5 years+178.9%+3.3%

FULC Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+22.2%-18.0%+51.2%
5 y5-yearat high+178.9%-18.0%+244.1%
alltimeall timeat high>+9999.0%-18.0%+354.6%

Fulcrum Therapeutics Shareholders Equity History

DateAnnualQuarterly
Dec 2024
-
$243.03 M(-5.5%)
Dec 2024
$243.03 M(+3.3%)
-
Sep 2024
-
$257.29 M(-6.0%)
Jun 2024
-
$273.79 M(+28.2%)
Mar 2024
-
$213.59 M(-9.2%)
Dec 2023
$235.19 M(+18.2%)
$235.19 M(-7.9%)
Sep 2023
-
$255.46 M(-7.2%)
Jun 2023
-
$275.43 M(-7.0%)
Mar 2023
-
$296.26 M(+48.9%)
Dec 2022
$198.94 M(-6.0%)
$198.94 M(-10.1%)
Sep 2022
-
$221.41 M(+37.7%)
Jun 2022
-
$160.75 M(-15.0%)
Mar 2022
-
$189.16 M(-10.6%)
DateAnnualQuarterly
Dec 2021
$211.54 M(+122.2%)
$211.54 M(-8.3%)
Sep 2021
-
$230.61 M(+108.0%)
Jun 2021
-
$110.89 M(-13.2%)
Mar 2021
-
$127.75 M(+34.2%)
Dec 2020
$95.18 M(+9.2%)
$95.18 M(-9.3%)
Sep 2020
-
$104.98 M(-14.0%)
Jun 2020
-
$122.13 M(+72.9%)
Mar 2020
-
$70.63 M(-19.0%)
Dec 2019
$87.15 M(+14.7%)
$87.15 M(-14.7%)
Sep 2019
-
$102.13 M(+91.1%)
Jun 2019
-
$53.45 M(-18.3%)
Mar 2019
-
$65.45 M(-13.9%)
Dec 2018
$76.00 M(+5648.9%)
$76.00 M
Dec 2017
$1.32 M
-

FAQ

  • What is Fulcrum Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Fulcrum Therapeutics?
  • What is Fulcrum Therapeutics annual shareholders equity year-on-year change?
  • What is Fulcrum Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Fulcrum Therapeutics?
  • What is Fulcrum Therapeutics quarterly shareholders equity year-on-year change?

What is Fulcrum Therapeutics annual stockholders equity?

The current annual shareholders equity of FULC is $243.03 M

What is the all time high annual shareholders equity for Fulcrum Therapeutics?

Fulcrum Therapeutics all-time high annual stockholders equity is $243.03 M

What is Fulcrum Therapeutics annual shareholders equity year-on-year change?

Over the past year, FULC annual stockholders equity has changed by +$7.84 M (+3.33%)

What is Fulcrum Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of FULC is $243.03 M

What is the all time high quarterly shareholders equity for Fulcrum Therapeutics?

Fulcrum Therapeutics all-time high quarterly stockholders equity is $296.26 M

What is Fulcrum Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, FULC quarterly stockholders equity has changed by +$7.84 M (+3.33%)